CDSCO
- Status: likely_approved
Biaxin (clarithromycin) regulatory status in India.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. CDSCO has authorised it.
Generic (originally Abbott/AbbVie) is the originator. The local marketing authorisation holder may differ — check the official source linked above.